Market Capitalization (Millions $) |
1 |
Shares
Outstanding (Millions) |
7,169 |
Employees |
- |
Revenues (TTM) (Millions $) |
1 |
Net Income (TTM) (Millions $) |
0 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Multicell Technologies, Inc.
Multicell Technologies, Inc. is a publicly traded biopharmaceutical company that focuses on the development and commercialization of pharmaceutical drugs, particularly in the field of regenerative medicine. The company's main objective is to improve the treatment of complex medical conditions by utilizing their proprietary technology called the ImmCelz platform, which involves the use of immune cells to treat a range of diseases. Multicell Technologies aims to address unmet medical needs and deliver innovative therapies for patients worldwide.
|